​

Medtronic (MDT) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

MDT Stock Forecast

Medtronic (MDT) stock forecast, based on 49 Wall Street analysts, predicts a 12-month average price target of $111.50, with a high of $120.00 and a low of $103.00. This represents a 9.32% increase from the last price of $101.99.

$75 $84 $93 $102 $111 $120 High: $120 Avg: $111.5 Low: $103 Last Closed Price: $101.99

MDT Stock Rating

Medtronic stock's rating consensus is Buy, based on 49 Wall Street analysts. The breakdown includes 1 Strong Buy (2.04%), 25 Buy (51.02%), 23 Hold (46.94%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 49 23 25 1 Strong Sell Sell Hold Buy Strong Buy

MDT Price Target Upside V Benchmarks

TypeNameUpside
StockMedtronic9.32%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks16.71%

Price Target Trends

1M3M12M
# Anlaysts5810
Avg Price Target$112.60$109.38$108.30
Last Closing Price$101.99$101.99$101.99
Upside/Downside10.40%7.25%6.19%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 2541216--32
Nov, 25412151-32
Oct, 25412151-32
Sep, 25412151-32
Aug, 2541313-131
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 20, 2025Barclays$111.00$100.3410.62%8.83%
Nov 19, 2025Lee HambrightBernstein$111.00$100.3410.62%8.83%
Nov 19, 2025Mike KratkyLeerink Partners$120.00$100.8019.05%17.66%
Nov 19, 2025Matthew TaylorJefferies$110.00$100.809.13%7.85%
Nov 19, 2025David RomanGoldman Sachs$111.00$100.8010.12%8.83%
Oct 31, 2025Lee HambrightBernstein$98.00$91.177.49%-3.91%
Oct 15, 2025Truist Financial$103.00$95.268.13%0.99%
Oct 10, 2025RBC Capital$111.00$95.7315.95%8.83%
Aug 26, 2025David ToungArgus Research$115.00$92.1824.76%12.76%
Jan 08, 2025Lee HambrightBernstein$93.00$82.6812.48%-8.81%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 20, 2025BarclaysOverweightOverweighthold
Nov 19, 2025Leerink PartnersOutperformOutperformhold
Nov 19, 2025JefferiesHoldHoldhold
Nov 14, 2025Cowen & Co.BuyBuyhold
Nov 14, 2025Piper SandlerNeutralNeutralhold
Oct 31, 2025BernsteinOutperformOutperformhold
Oct 10, 2025RBC CapitalOutperformOutperformhold
Oct 07, 2025CitigroupBuyBuyhold
Jul 15, 2025Morgan StanleyOverweightOverweighthold
Jul 11, 2025BTIGNeutralNeutralhold

Financial Forecast

EPS Forecast

$2 $3 $4 $5 $6 $7 $8 Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$2.68$3.75$2.83$2.77$3.63----
Avg Forecast$4.36$5.66$5.27$5.20$5.45$5.84$6.30$6.85$7.36
High Forecast$4.40$5.72$5.33$5.23$5.47$5.88$6.65$6.92$7.44
Low Forecast$4.31$5.60$5.22$5.19$5.44$5.76$4.95$6.78$7.29
Surprise %-38.53%-33.75%-46.30%-46.73%-33.39%----

Revenue Forecast

$25B $29B $33B $37B $41B $45B Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$30.12B$31.69B$31.23B$32.36B$33.54B----
Avg Forecast$30.06B$32.02B$30.94B$32.22B$33.57B$35.14B$36.89B$39.10B$41.02B
High Forecast$30.30B$32.28B$31.25B$32.26B$33.65B$35.36B$36.91B$39.42B$41.35B
Low Forecast$29.82B$31.76B$30.63B$32.16B$33.47B$34.94B$36.88B$38.79B$40.70B
Surprise %0.20%-1.05%0.94%0.44%-0.11%----

Net Income Forecast

$3B $4B $6B $7B $9B $10B Apr 21 Apr 22 Apr 23 Apr 24 Apr 25 Apr 26 Apr 27 Apr 28 Apr 29
Apr 21Apr 22Apr 23Apr 24Apr 25Apr 26Apr 27Apr 28Apr 29
Reported$3.61B$5.04B$3.76B$3.68B$4.66B----
Avg Forecast$3.56B$4.39B$7.02B$4.29B$7.26B$7.74B$7.72B$9.11B$9.79B
High Forecast$4.28B$5.27B$7.09B$5.15B$7.28B$7.82B$8.85B$9.21B$9.90B
Low Forecast$2.85B$3.51B$6.94B$3.43B$7.24B$7.66B$6.58B$9.02B$9.70B
Surprise %1.18%14.78%-46.43%-14.27%-35.77%----

MDT Forecast FAQ

Is Medtronic stock a buy?

Medtronic stock has a consensus rating of Buy, based on 49 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 25 Buy, 23 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Medtronic is a favorable investment for most analysts.

What is Medtronic's price target?

Medtronic's price target, set by 49 Wall Street analysts, averages $111.5 over the next 12 months. The price target range spans from $103 at the low end to $120 at the high end, suggesting a potential 9.32% change from the previous closing price of $101.99.

How does Medtronic stock forecast compare to its benchmarks?

Medtronic's stock forecast shows a 9.32% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical device stocks industry (16.71%).

What is the breakdown of analyst ratings for Medtronic over the past three months?

  • December 2025: 12.50% Strong Buy, 37.50% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 12.50% Strong Buy, 37.50% Buy, 46.88% Hold, 3.12% Sell, 0% Strong Sell.
  • October 2025: 12.50% Strong Buy, 37.50% Buy, 46.88% Hold, 3.12% Sell, 0% Strong Sell.

What is Medtronic’s EPS forecast?

Medtronic's average annual EPS forecast for its fiscal year ending in April 2026 is $5.84, marking a 60.88% increase from the reported $3.63 in 2025. Estimates for the following years are $6.3 in 2027, $6.85 in 2028, and $7.36 in 2029.

What is Medtronic’s revenue forecast?

Medtronic's average annual revenue forecast for its fiscal year ending in April 2026 is $35.14B, reflecting a 4.79% increase from the reported $33.54B in 2025. The forecast for 2027 is $36.89B, followed by $39.1B for 2028, and $41.02B for 2029.

What is Medtronic’s net income forecast?

Medtronic's net income forecast for the fiscal year ending in April 2026 stands at $7.74B, representing an 66.11% increase from the reported $4.66B in 2025. Projections indicate $7.72B in 2027, $9.11B in 2028, and $9.79B in 2029.